We are a highly innovative biotech company developing new microbiome therapies to treat elevated serum urate and to reduce onset of gout. The IP protected oral products are all natural and composed of selected bacteria that are recognised as safe.
We raised already 160k SFR from Angel investors in Switzerland and Denmark - and would need 440k SFr more for the pre-clinical development. Our valuation of the company is currently 2.0 Mio SFR